Shallots for Blood Sugar Control
The blood-sugar claim is the one most often made for shallots and the one with the weakest direct support. There is exactly one well-known published experiment that gave shallot to a living animal and measured glucose, and its subjects were rats. Everything else you will read is either about the common onion, about garlic, about isolated quercetin, or about a different plant altogether that happens to be marketed in English as "Persian shallot."
What follows sorts that out. It also does something the marketing never does: it points out that the shallot's own contribution to blood sugar has a second side. Shallots are rich in fructans, and for the large minority of readers with irritable bowel syndrome, the practical effect of eating more shallots is not better glucose control but abdominal pain.
Table of Contents
- What Is Being Claimed, and by Whom
- Four Plausible Mechanisms
- Shallot-Specific Evidence: The Whole of It
- Onion: Where the Human Data Actually Is
- Garlic: Randomized Trials in Type 2 Diabetes
- Isolated Quercetin and Glycemic Control
- The Glycemic Load of a Shallot Itself
- Fructans: Prebiotic Benefit and FODMAP Cost
- What This Means If You Have Prediabetes or Type 2 Diabetes
- Practical Kitchen Guidance
- Red Flags in Shallot Blood-Sugar Marketing
- What Would Change This Page
- Cautions
- Key Research Papers
- Connections
What Is Being Claimed, and by Whom
Three versions of the claim circulate, and they are not equally defensible.
The strong version — that shallots lower fasting glucose or HbA1c, or help "reverse" type 2 diabetes — has no human evidence of any kind. It appears mainly in supplement copy and in aggregated health articles that cite reviews rather than primary studies, so the species substitution happens one layer down where nobody checks.
The moderate version — that shallots contain compounds shown to improve insulin sensitivity in animals — is true, and it is where this page's honest content sits. It is also much less useful than it sounds, because "shown in rats at extract doses" is a long way from "helps at dinner."
The weak but genuinely correct version — that shallots are a very low-carbohydrate, high-flavour vegetable that makes a diabetes-appropriate diet more palatable — almost never gets stated, because it does not sell anything. It is nonetheless the reason a person managing blood sugar should be glad shallots exist.
Four Plausible Mechanisms
Four routes from a shallot to a glucose reading have some experimental support somewhere in the allium literature. Tier for all four: preliminary — animal, cell or enzyme-assay work.
1. S-methylcysteine sulfoxide
This sulfur amino-acid derivative, abundant in onion-type alliums, is the single compound most often credited with allium glucose effects. Kumari and Augusti isolated S-methylcysteine sulfoxide from onions (Allium cepa Linn) and compared its antidiabetic and antioxidant effects against standard drugs in alloxan-diabetic rats, in the Indian Journal of Experimental Biology in 2002. Shallots contain the same class of precursors, being onion-type alliums, though the quantitative comparison between shallot and onion cultivars has not been mapped in the way phenolics have.
2. Quercetin and insulin signalling
Quercetin modulates NF-kappa-B and inflammatory signalling, and chronic low-grade inflammation is part of how insulin resistance is maintained. Quercetin has also been reported to influence glucose transporter expression and pancreatic function in animal models. Shallots deliver quercetin in an unusually well-absorbed glucoside form, which makes this route more credible for shallot than for many plants — see the Cholesterol and Heart Health page for the bioavailability evidence.
3. Alpha-glucosidase inhibition
Several allium extracts inhibit intestinal alpha-glucosidase in enzyme assays, which is the same target the drug acarbose acts on. Slowing carbohydrate digestion blunts the post-meal glucose peak. This is a chemistry-bench result: an inhibitory concentration in a cuvette says nothing about what a portion of food does inside a human intestine, where the extract is diluted thousands of times.
4. Fructans and colonic fermentation
Shallot fructans reach the colon undigested and are fermented into short-chain fatty acids, which have been linked to incretin release and improved insulin sensitivity in mechanistic work. Prebiotic fibre is a real and reasonably well-supported dietary lever. It is also, for a substantial minority of readers, the reason shallots cause symptoms.
Shallot-Specific Evidence: The Whole of It
This section is short because the literature is short. It is stated in full rather than summarized so you can see how thin it is.
The one experiment people cite. Jalal, Bagheri, Moghimi and Rasuli tested the hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance, published in the Journal of Clinical Biochemistry and Nutrition in 2007. Rats made insulin-resistant by high-fructose feeding were given aqueous extracts; the study reported improvements in glucose handling. It is a legitimate, informative rodent study. Tier: preliminary — animal.
Related shallot work in the same territory. Wongmekiat, Leelarugrayub and Thamprasert reported that shallot (Allium ascalonicum L.) extract reduced cyclosporine-induced nephrotoxicity in rats, in Food and Chemical Toxicology in 2008 — oxidative-stress protection rather than glucose, but cited in metabolic contexts. Leelarungrayub, Rattanapanone, Chanarat and Gebicki quantified the antioxidant properties of garlic and shallot preparations in Nutrition in 2006, which is a chemical comparison rather than a metabolic outcome.
What does not exist. No randomized trial of shallot in humans with prediabetes or type 2 diabetes. No crossover study of a shallot-containing meal versus a control meal on postprandial glucose. No continuous-glucose-monitor study. No fasting-insulin or HOMA-IR study. Not one. If a page tells you shallots "have been shown to lower blood sugar," it is describing a rat.
The species trap, again. Iranian research groups have published a fair amount on moosir, sold in English as Persian shallot, which is Allium hirtifolium or Allium stipitatum. Some of that work touches glucose and metabolic syndrome, including at least one randomized double-blind trial. It is a different species with a different organosulfur profile, gathered wild in the Zagros mountains, and it is not the bulb sold in supermarkets as a shallot. Checking the Latin binomial is the single most valuable habit you can bring to this topic.
Onion: Where the Human Data Actually Is
The shallot is now generally classified as a variety of Allium cepa, so onion evidence is the most legitimate extension available — closer than garlic, though still not the same food.
A small human study of raw onion. Eldin, Ahmed and Elwahab published a preliminary study of the clinical hypoglycemic effects of Allium cepa (red onion) in type 1 and type 2 diabetic patients, in Environmental Health Insights in 2010, reporting reductions in fasting glucose after raw onion ingestion. Tier: small preliminary human study — not a randomized controlled trial, and it should not be described as one.
Raw onion in a randomized trial. Ebrahimi-Mamaghani, Saghafi-Asl, Pirouzpanah and Asghari-Jafarabadi ran a randomized controlled clinical trial of raw red onion consumption on metabolic features in overweight or obese women with polycystic ovary syndrome, published in the Journal of Obstetrics and Gynaecology Research in 2014. PCOS is a condition of insulin resistance, so this is directly relevant — and it tested the actual vegetable, which is rare. Tier: randomized clinical trial — of red onion.
Reviews and animal syntheses. Akash, Rehman and Chen reviewed the spice plant Allium cepa as a dietary supplement for treatment of type 2 diabetes mellitus in Nutrition in 2014. Kook, Kim and Choi performed a meta-analysis of the antidiabetic effect of onion and garlic in experimental diabetic rats in the Journal of Medicinal Food in 2009 — note carefully that this is a meta-analysis of animal studies, a design that is frequently mis-cited as human evidence. Galavi, Hosseinzadeh and Razavi reviewed the effects of Allium cepa and its active constituents on metabolic syndrome in the Iranian Journal of Basic Medical Sciences in 2021.
Onion peel in animals. Jung, Lim, Moon, Kim and Kwon reported that onion peel extract ameliorated hyperglycemia and insulin resistance in high-fat-diet and streptozotocin-induced diabetic rats, in Nutrition and Metabolism in 2011. Bang, Kim and Cho reported alterations in blood glucose, serum lipids and renal oxidative stress in diabetic rats supplemented with onion, in Nutrition Research and Practice in 2009. Yoshinari, Shiojima and Igarashi reported anti-obesity effects of onion extract in Zucker diabetic fatty rats in Nutrients in 2012.
The pattern is consistent and the ceiling is low. Onion-family alliums produce measurable improvements in glucose handling in diabetic rodents, fairly reliably. In humans the signal shrinks to small effects in small studies, mostly with raw onion at quantities most people would not eat daily. Nothing in that pattern predicts a clinically meaningful effect from seasoning your food with shallots.
Garlic: Randomized Trials in Type 2 Diabetes
Garlic is the only allium with a real randomized-trial base in diabetes, and it is included here precisely so you can see the ceiling.
Wang, Zhang, Lan and Wang published a meta-analysis of randomized controlled trials on the effect of garlic supplementation in the management of type 2 diabetes mellitus, in Food and Nutrition Research in 2017, reporting modest reductions in fasting blood glucose. Ashraf, Khan and Ashraf reported that garlic supplementation added to a standard antidiabetic agent provided better diabetic control in type 2 diabetes patients, in the Pakistan Journal of Pharmaceutical Sciences in 2011. Tier: randomized clinical trials — of garlic supplements.
Two things follow. First, these are trials of standardized garlic preparations at supplement doses, not of a vegetable. Second, garlic's dominant organosulfur chemistry is allicin-derived, while shallots produce very little allicin — so even the mechanistic bridge is partial. Garlic's diabetes evidence is the strongest in the genus, it is modest in size, and it is not shallot's.
Isolated Quercetin and Glycemic Control
Since shallots are quercetin-rich in a well-absorbed form, the quercetin trials are the most relevant supplement literature.
Ostadmohammadi, Milajerdi, Ayati and colleagues published a systematic review and meta-analysis of randomized controlled trials of quercetin supplementation on glycemic control among patients with metabolic syndrome and related disorders, in Phytotherapy Research in 2019. The pooled effects were small and inconsistent across outcomes. Tier: randomized clinical trials — of purified quercetin, typically 150 to 500 mg per day.
The arithmetic that ends the argument. Those trial doses are an order of magnitude above what any realistic diet delivers; a quercetin-rich day of eating supplies perhaps a few tens of milligrams. So even if you accept the supplement results at face value, a portion of shallots cannot deliver a comparable dose. Shallots being a better quercetin source than a sweet white onion is a real fact about food quality. It does not scale up into a glycemic intervention.
The Glycemic Load of a Shallot Itself
Here is a shallot benefit for blood sugar that requires no trial, no mechanism and no extrapolation, and it is the most practically useful thing on this page.
A shallot is mostly water. The carbohydrate it contains is present in small absolute amounts per serving, and a meaningful share of it is fructans, which humans cannot digest into glucose at all — the fructan fraction contributes to fermentation, not to your blood glucose curve. A tablespoon or two of minced shallot in a dish contributes a negligible glycemic load while doing a large amount of flavour work.
Why that matters more than it sounds: the hardest part of eating for blood-sugar control is not knowing what to eat, it is finding the restricted version of a meal palatable enough to repeat for years. Shallots make lentils, beans, brown rice, eggs, fish, greens and cabbage taste like food you look forward to. A vegetable that makes a sustainable diet sustainable is doing more for a person's HbA1c than any of the mechanisms discussed above.
Two caveats keep this honest. Caramelization concentrates sugars — slowly cooked shallots taste sweet because they are sweeter, and a large quantity of shallot jam is not a free food. And fried shallot crisps come with the oil they were fried in, which is a calorie question rather than a glucose one but still a real one.
Fructans: Prebiotic Benefit and FODMAP Cost
The same compound is on both sides of the ledger, and most writing about shallots only mentions one side.
The benefit. Inulin-type fructans are prebiotic. They feed colonic bacteria and yield short-chain fatty acids that have plausible links to insulin sensitivity and appetite regulation. This is a genuine reason to eat alliums, and it applies to shallots as much as to leeks, garlic and Jerusalem artichokes.
The cost. Fructans are the "F" in FODMAP. Tuck, Ly, Bogatyrev and colleagues measured the fermentable short-chain carbohydrate content of common plant-based and processed foods suitable for a low-FODMAP diet, in the Journal of Human Nutrition and Dietetics in 2018. Halmos, Power, Shepherd, Gibson and Muir showed in a controlled feeding study in Gastroenterology in 2014 that a diet low in FODMAPs reduces symptoms of irritable bowel syndrome, and Shepherd and Gibson set out the practical dietary management approach in the Journal of the American Dietetic Association in 2006. Shallots are excluded during the elimination phase. Tier: randomized and controlled human feeding studies — strong evidence, in the opposite direction from the benefit.
The workaround worth knowing. Fructans are water-soluble and not oil-soluble. Infuse oil with shallots, strain out and discard the solids, and you keep the flavour without the fructans — a trick that lets people with IBS cook Southeast Asian food again. See the botulism warning in Cautions before you make a jar of it. Fried shallot crisps are the solids themselves and are not a workaround.
What This Means If You Have Prediabetes or Type 2 Diabetes
A direct answer, because this is what most readers came for.
- Eat shallots freely. They are a near-zero-glycemic-load vegetable with a high flavour return. Use them generously in cooking. Nothing about diabetes argues against them.
- Do not expect them to lower your glucose. No human study supports that, and the plants with the best evidence in the genus produce only modest effects at supplement doses.
- Do not buy shallot capsules. No established dose, no standardization, no human efficacy data, and a real risk the product contains a different species.
- Do not stop or reduce medication. Metformin, GLP-1 receptor agonists, SGLT2 inhibitors and insulin have effects orders of magnitude larger than any food discussed here.
- If you want to test it yourself, do it properly. If you use a glucose meter or a continuous monitor, you are in a position to run a fair personal comparison: the same meal with and without shallots, repeated several times, at the same time of day. That is a better use of your attention than any claim on this page. See Hemoglobin A1C and Fasting Insulin for the longer-term measures.
- If you have IBS as well as diabetes, which is common, the fructan problem may outweigh everything else. Use the infused-oil approach.
Practical Kitchen Guidance
- Some raw, some cooked. Raw shallot in a vinaigrette or a quick pickle keeps the sulfur chemistry and the vitamin C. Slow-cooked shallot loses both and gains sweetness.
- Chop and wait ten minutes before heating if the sulfur compounds are the point. Alliinase needs time and is destroyed by heat.
- Pickled shallots are the best of both. The Vietnamese and Thai tradition of vinegar-pickled shallots is a genuinely good way to eat them close to raw, and it pairs well with rich food.
- Peel only the papery skin. The fleshy layer directly underneath is the most flavonol-dense edible part of the bulb and is usually thrown away with the skin.
- Watch what the shallots are carrying. A shallot-heavy curry paste is excellent. The same paste fried in a large volume of oil and served over white rice is a different meal for your glucose, and the shallots are not the variable that changed.
- Store them dry and airy, not sealed and not refrigerated, where they sprout and soften.
Red Flags in Shallot Blood-Sugar Marketing
Five specific tells, all of which you will encounter if you look for shallot supplements.
- "Clinically proven" with a citation to a rodent study. The Jalal rat study is the usual source. Check whether the subjects had four legs.
- A Latin name that is not Allium cepa Aggregatum Group or Allium ascalonicum. If the label or the cited trial says hirtifolium or stipitatum, the evidence belongs to a different plant.
- Standardized allicin content. Shallots produce very little allicin proper — their chemistry is isoalliin-derived. An allicin-standardized "shallot" product is either mislabelled or contains garlic.
- A meta-analysis cited without its species or its subjects. The Kook 2009 meta-analysis is a meta-analysis of experimental diabetic rats. It gets cited as though it pooled human trials.
- Any claim to replace or reduce medication. This is the one that causes actual harm. No food does this, and stopping diabetes medication on the strength of a vegetable is dangerous.
What Would Change This Page
- A randomized crossover trial of a standardized shallot-containing meal versus a matched control on postprandial glucose and insulin, which would be inexpensive and has simply never been done.
- A trial of a defined daily quantity of whole shallot over twelve weeks in prediabetes, with HbA1c or HOMA-IR as the primary endpoint.
- Quantitative comparison of S-methylcysteine sulfoxide content between shallot cultivars and common onion, which would tell us whether the shallot's advantage in phenolics extends to the sulfur compound most credited with glucose effects.
Until then, the accurate summary is: promising in rats, unmeasured in people, and excellent food regardless.
Cautions
FODMAP intolerance and IBS. Shallots are high in fructans and are excluded during the elimination phase of a low-FODMAP diet. For people with irritable bowel syndrome they reliably trigger bloating, wind and pain. Shallot-infused oil with the solids strained out is generally tolerated because fructans are not oil-soluble; fried shallot crisps are not a workaround. See Irritable Bowel Syndrome.
Reflux and gastritis. Alliums, especially raw, commonly trigger gastro-oesophageal reflux — worth noting because this page suggests eating some raw. See GERD.
Hypoglycemia risk with medication. This caution is theoretical for shallot food but not for concentrated allium supplements. If you take insulin or a sulfonylurea and you add a garlic, onion-extract or quercetin supplement, monitor your glucose more closely for the first couple of weeks and tell your prescriber. The relevant hazard is additive glucose lowering, and the people most likely to encounter it are those already at risk of lows.
Anticoagulants, antiplatelets and surgery. Garlic has a documented antiplatelet effect and isolated quercetin inhibits platelet aggregation in human pilot work. Culinary shallots are fine on warfarin, a direct oral anticoagulant, clopidogrel or aspirin. Concentrated supplements should be cleared with your prescriber and stopped one to two weeks before planned surgery.
Botulism risk from alliums in oil. Because this page recommends shallot-infused oil, the warning is mandatory. Alliums in oil at room temperature create the anaerobic, low-acid conditions Clostridium botulinum requires, and garlic-in-oil has caused documented outbreaks. Make small batches, refrigerate immediately, use within a few days, or freeze in portions.
Allergy and contact dermatitis. Uncommon but real; allium allergy can cause oral allergy symptoms, rhinitis, asthma or rarely anaphylaxis, and occupational contact dermatitis is well documented in cooks.
Toxic to dogs and cats. All alliums cause Heinz-body haemolytic anaemia in dogs and cats; cats are especially sensitive. Cooked shallots, shallot powder, fried crisps and leftovers all count. Contact a vet if a pet eats a meaningful quantity.
Key Research Papers
Each entry names the plant and the subjects, because that is where this topic goes wrong. Links are PubMed topic searches so you see each paper in context.
- Shallot and garlic, rats. Jalal R, Bagheri SM, Moghimi A, Rasuli MB. Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance. Journal of Clinical Biochemistry and Nutrition, 2007. Find on PubMed
- Shallot, rats. Wongmekiat O, Leelarugrayub N, Thamprasert K. Beneficial effect of shallot (Allium ascalonicum L.) extract on cyclosporine nephrotoxicity in rats. Food and Chemical Toxicology, 2008. Find on PubMed
- Shallot vs garlic, chemical assay. Leelarungrayub N, Rattanapanone V, Chanarat N, Gebicki JM. Quantitative evaluation of the antioxidant properties of garlic and shallot preparations. Nutrition, 2006. Find on PubMed
- Onion, small human study. Eldin IM, Ahmed EM, Elwahab HM. Preliminary study of the clinical hypoglycemic effects of Allium cepa (red onion) in type 1 and type 2 diabetic patients. Environmental Health Insights, 2010. Find on PubMed
- Red onion, randomized trial. Ebrahimi-Mamaghani M, Saghafi-Asl M, Pirouzpanah S, Asghari-Jafarabadi M. Effects of raw red onion consumption on metabolic features in overweight or obese women with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research, 2014. Find on PubMed
- Onion, review. Akash MS, Rehman K, Chen S. Spice plant Allium cepa: dietary supplement for treatment of type 2 diabetes mellitus. Nutrition, 2014. Find on PubMed
- Onion and garlic, meta-analysis of ANIMAL studies. Kook S, Kim GH, Choi K. The antidiabetic effect of onion and garlic in experimental diabetic rats: meta-analysis. Journal of Medicinal Food, 2009. Find on PubMed
- Onion constituent, rats. Kumari K, Augusti KT. Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa Linn) as compared to standard drugs in alloxan diabetic rats. Indian Journal of Experimental Biology, 2002. Find on PubMed
- Onion peel, rats. Jung JY, Lim Y, Moon MS, Kim JY, Kwon O. Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats. Nutrition and Metabolism, 2011. Find on PubMed
- Onion, rats. Bang MA, Kim HA, Cho YJ. Alterations in the blood glucose, serum lipids and renal oxidative stress in diabetic rats by supplementation of onion (Allium cepa Linn). Nutrition Research and Practice, 2009. Find on PubMed
- Garlic, meta-analysis of randomized trials. Wang J, Zhang X, Lan H, Wang W. Effect of garlic supplement in the management of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Food and Nutrition Research, 2017. Find on PubMed
- Garlic, randomized trial. Ashraf R, Khan RA, Ashraf I. Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients. Pakistan Journal of Pharmaceutical Sciences, 2011. Find on PubMed
- Quercetin, meta-analysis of randomized trials. Ostadmohammadi V, Milajerdi A, Ayati E, et al. Effects of quercetin supplementation on glycemic control among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 2019. Find on PubMed
- Shallot, human pharmacokinetics. Wiczkowski W, Romaszko J, Bucinski A, et al. Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. The Journal of Nutrition, 2008. Find on PubMed
- Human controlled feeding. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology, 2014. Find on PubMed
- Food composition. Tuck C, Ly E, Bogatyrev A, et al. Fermentable short-chain carbohydrate (FODMAP) content of common plant-based foods and processed foods suitable for a low-FODMAP diet. Journal of Human Nutrition and Dietetics, 2018. Find on PubMed
Live PubMed searches
- Allium ascalonicum, glucose and insulin
- Allium cepa and diabetes, randomized trials
- S-methylcysteine sulfoxide and glucose
- Quercetin and insulin resistance
- Inulin-type fructans and insulin sensitivity
- Fructans, FODMAPs and IBS
Connections
- All Herbs
- Shallot Benefits hub — the evidence-tier system and the three plants called "shallot."
- Shallot (Allium ascalonicum) — botany, taxonomy and culinary technique.
- Shallots for Cholesterol and Heart Health — quercetin bioavailability and the cardiovascular claims.
- Type 2 Diabetes — the condition these claims target, and what actually works.
- Insulin Resistance — the mechanism the rodent shallot study was probing.
- Prediabetes — where dietary change has the largest measured effect.
- Metabolic Syndrome — the endpoint used in the Persian-shallot trial that gets miscited.
- Hemoglobin A1C — the three-month average worth tracking.
- Fasting Insulin — the earlier marker of insulin resistance.
- Fenugreek — a herb with considerably better human glucose data than shallot.
- Berberine — the plant compound with the strongest glycemic trial base, for comparison.
- Onions — the species that holds the human evidence borrowed on this page.
This page is educational and is not medical advice. Shallots are food. They are not a treatment for diabetes, prediabetes or insulin resistance, and no human study has shown that eating them lowers blood glucose. Never reduce or stop metformin, insulin, a GLP-1 receptor agonist, an SGLT2 inhibitor or any other prescribed medication on the basis of a dietary change. If you take insulin or a sulfonylurea and you start a concentrated allium or quercetin supplement, monitor your glucose closely and tell your prescriber.